Member Info for Nolupus

Very comical our TIM,

"Active discussions"

"There has been some interest in " ... Tim " yes , there has "..........in IMM and the the drug ?" ...euh in
lupuzor yea....Right.."absolutely " .....

Trek,

With all due respect, i am inclined to believe what i see and not what i hear from Tim.....
The Incanthera investment was just the last straw for me !!
Those that have listened to Tim, well they have had their dreams turned to nightmares,imo

A chip and a chair is all that is left ....imv

Hope you're right scoredagainsteps because if you're wrong the next support level is under 8p

No, i am not a punter...

PinkPanther10,
Worth a punt ? Are we investing or at the races ? :-)

The odds are very much against IMM doing another P3 trial in Lupus , Imo
Why ?
The cost and also the time...IMV The clock is ticking on the patents

but everyone to their own opinions....

Well don't be greedy...If you can get the 4 figure divided by two ....That will keep the Mrs very happy :-)

I hope you got those YU that i mentioned ?

And we should'nt forget the ITW that Tim gave after the results when he said that
IMM had a least two years cash in the bank ...and here we are a year later with Lanstead :-)

One would think that Tim is a used car salesman but NO ...He is an accountant :-)

Interesting that Tim made no mention on the Incanthera situation :-)

@Canis
regarding the cash position before the recent placing....let me remind people of some of my posts dated may/june

"I agree, Cash burn should decrease after the extension trial is paid for, but the Nucant and Ureka teams still have to be paid until they find a way forward....The Map program has been "postponed" so that means the estimted cost of £1 million will be saved...

But saying that, the december 2018 cash situation was £4.9 million
Trade and other payables (913,907)
Leaves 4 mill

take away the Administrative expenses per month of £ 138367 for 5 months = 691 837

leaves £ 3.3 mill approx

Now we can substract the R&D costs for the 5 months gone by since dec 2018 to see what the current
cash position is like....remember that IMM are still paying for the extension trial + the Nucant team + the Ureka team

So please ....calculate ....
---------------------------------------------------------------------------------
RE: Good cash position24 May 2019 10:01
Shut Nolupus up for a while ?? Good cash position ??

Loss of £7.2 million for the year ..£.600K loss a month

Cash left ( december 2018 ) £4.9 million ...

If one is loosing 600k a month, i will let you calculate how many months (and not years) cash is left ..

@Canis,

It's in everyones interest for the sp to stay above a certain level...but even it is does'nt Lanstead won't lose out....

Being realistic , this new Lanstead deal is only the beginning because 2.6 million won't last very long, imv

IMM will need to change course quickly , imo, as the Cashburn is just too high ....

Nucant and Ureka are still draining the limited ressources and the "unfortunate " Incanthera investment is still blocked...

IMM needs CHANGE and some good news in the very near future..imo

@pinkPanther10

Lanstead presumably have a plan ??

They are in a win/win situation ....Even if the SP goes down, they won't lose anything

But

Their money is not going to last that long due to the cashburn so........IMM will have to come up with the "goods" in the next few months imo

Ceo86,

My job is not to annoy people, that 's just my pastime with the pump and dump crowd

The BB is deserted by the "strong buyers"....

But it might just be the time to buy.....Time will tell

Just Zimmer getting diluted like all the PI

Halfbutt,

Am i hated ??
OMG

YoungHarry,

"incompatible with running a PIII trial at the same time" ??

Can you give us one link, where IMM have stated that they will be doing another P3 ?

We already knew that safety profile was very good, so nothing new there

Retour de Renard,

The timing of these RNS just shows a total lack of respect for the PI...imv

Well, a lot more shares on the market on Monday

Retour de renard, you are incorrect in stating that FDA approval for another P3 TRIAL could take years

Months yes, but years NO